We are live on ! Find out more
Qube Research & Technologies (QRT)

Qube Research & Technologies (QRT) Portfolio holdings

AUM $108B
1-Year Est. Return 37.29%
This Fund
S&P 500
This Quarter Est. Return
+2.03%
1 Year Est. Return
+37.29%
3 Year Est. Return
+69.2%
5 Year Est. Return
+43.82%
10 Year Est. Return
AUM
$23.2B
AUM Growth
+$4.57B
Cap. Flow
+$933M
Cap. Flow %
4.01%
Top 10 Hldgs %
24.47%
Holding
3,215
New
812
Increased
777
Reduced
812
Closed
734

Top Buys

Rank Stock Value
1
FRC
First Republic Bank
FRC
+$286M
2
CI icon
Cigna
CI
+$183M
3
HON icon
Honeywell
HON
+$156M
4
COP icon
ConocoPhillips
COP
+$150M
5
ABT icon
Abbott
ABT
+$120M

Sector Composition

Rank Sector Weight
1 Miscellaneous 27.16%
2 Technology 13.42%
3 Consumer Discretionary 11.26%
4 Financials 11.11%
5 Healthcare 11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TVRD
2176
Tvardi Therapeutics
TVRD
$21.9M
$74.4K ﹤0.01%
+421
New +$141K
FENY icon
2177
Fidelity MSCI Energy Index ETF
FENY
$2.15B
$73.1K ﹤0.01%
+3,259
New +$75.9K
ESPR
2178
DELISTED
Esperion Therapeutics
ESPR
$71.8K ﹤0.01%
+45,133
New +$233K
SDIV icon
2179
Global X SuperDividend ETF
SDIV
$1.21B
$70.8K ﹤0.01%
+3,075
New +$75.4K
FREL icon
2180
Fidelity MSCI Real Estate Index ETF
FREL
$1.42B
$70.5K ﹤0.01%
2,830
-2,890
-51% -$74.6K
TCS
2181
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
$68.4K ﹤0.01%
+1,330
New +$88.5K
TSP
2182
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
$68.3K ﹤0.01%
+46,489
New +$87.9K
ORMP icon
2183
Oramed Pharmaceuticals
ORMP
$195M
$68.3K ﹤0.01%
31,309
-11,522
-27% -$36.6K
PAYS icon
2184
Paysign
PAYS
$709M
$68.1K ﹤0.01%
18,766
-8,195
-30% -$28K
BBAX icon
2185
JPMorgan BetaBuilders Developed Asia Pacific-ex Japan ETF
BBAX
$6.75B
$68K ﹤0.01%
1,384
-7,145
-84% -$362K
ABUS icon
2186
Arbutus Biopharma
ABUS
$1B
$66.7K ﹤0.01%
+22,024
New +$62.1K
AVDE icon
2187
Avantis International Equity ETF
AVDE
$19.1B
$66.5K ﹤0.01%
+1,166
New +$65.7K
XAR icon
2188
State Street SPDR S&P Aerospace & Defense ETF
XAR
$5.4B
$65.8K ﹤0.01%
+563
New +$65.5K
RSKD icon
2189
Riskified
RSKD
$827M
$65.3K ﹤0.01%
+11,577
New +$64.3K
NAIL icon
2190
Direxion Daily Homebuilders & Supplies Bull 3X ETF
NAIL
$488M
$65.2K ﹤0.01%
1,458
ZOM
2191
DELISTED
Zomedica Corp.
ZOM
$65K ﹤0.01%
306,865
+119,591
+64% +$29.3K
AMLI
2192
DELISTED
American Lithium Corp. Common Stock
AMLI
$64.5K ﹤0.01%
+27,940
New +$82K
IVLU icon
2193
iShares MSCI Intl Value Factor ETF
IVLU
$4.67B
$64.5K ﹤0.01%
+2,600
New +$63.9K
PXF icon
2194
Invesco FTSE RAFI Developed Markets ex-US ETF
PXF
$3.02B
$63.4K ﹤0.01%
1,439
+850
+144% +$37.5K
NESR
2195
National Energy Services Reunited Corp
NESR
$3.25B
$62.9K ﹤0.01%
+11,960
New +$79K
URE icon
2196
ProShares Ultra Real Estate
URE
$51.8M
$62.8K ﹤0.01%
1,092
-789
-42% -$48.7K
DBEU icon
2197
Xtrackers MSCI Europe Hedged Equity ETF
DBEU
$777M
$62.5K ﹤0.01%
1,708
+1,369
+404% +$49.3K
BMY icon
2198
PUT
Bristol-Myers Squibb
BMY
$129B
$62.4K ﹤0.01%
+900
New +$63.5K
CWEB icon
2199
Direxion Daily CSI China Internet Index Bull 2X ETF
CWEB
$179M
$61.7K ﹤0.01%
1,211
-48
-4% -$2.67K
UGP icon
2200
Ultrapar
UGP
$8.05B
$61.4K ﹤0.01%
22,473
-255,586
-92% -$646K

Similar funds

Qube Research & Technologies (QRT)'s Q1 2023 Portfolio in Review

As of Q1 2023, Qube Research & Technologies (QRT) held 3,215 positions worth $23.2B, up 24% from $18.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Qube Research & Technologies (QRT) deployed $933M of net new capital in Q1 2023, opening 812 new positions and adding to 777 existing holdings. Its largest new stake was First Republic Bank: 2,786,874 shares worth $39M.

By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 15% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Apple, an estimated $180M trimmed.

  • Qube Research & Technologies (QRT)'s largest Q1 2023 buy was First Republic Bank: 2,786,874 shares worth $39M.
  • Qube Research & Technologies (QRT) added most to Cigna in Q1 2023, an estimated $183M increase.
  • Qube Research & Technologies (QRT)'s biggest Q1 2023 reduction was Apple, cutting an estimated $180M.
  • Qube Research & Technologies (QRT) fully exited Vertex Pharmaceuticals in Q1 2023, selling an estimated $123M.
  • Qube Research & Technologies (QRT)'s ten largest holdings make up 24% of its $23.2B portfolio in Q1 2023.
  • Qube Research & Technologies (QRT) opened 812 new positions and closed 734 in Q1 2023.
  • Qube Research & Technologies (QRT)'s portfolio value rose 24% quarter-over-quarter to $23.2B.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2023, filed 15 May 2023.